• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchCelcuity
    Picture of Celcuity logo

    CELC — Celcuity News Story

    $60.300.000.00%
    us flag iconLast trade - 00:00
    HealthcareAdventurousMid CapSucker Stock
    • Market Cap
      $2.95bn
    • Enterprise Value
      $2.95bn
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • CELC Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    CELC Dividends
    All News

    NASDAQ RESUMED AT 05:20 PM

    Picture of Celcuity logoCelcuity
    01/05/2026 22:20
    NASDAQ RESUMED  CELC.O  AT 05:20 PM
    

    Recent news on Celcuity

    See all news
    • U.S. STOCKS ON THE MOVE-Pyxis Oncology, MongoDB, United Therapeutics

      30/09/2026 18:48
    • U.S. STOCKS ON THE MOVE-Synopsys, Cboe, GameStop

      30/09/2026 17:34
    • Celcuity gains as breast cancer drug launches in US

      30/09/2026 14:19
    • U.S. STOCKS ON THE MOVE -Nebius, Securitize, Viant Technology

      17/09/2026 18:40
    • U.S. STOCKS ON THE MOVE -GlobalFoundries, Lucid, Phillips 66

      17/09/2026 16:41

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.